Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1406 of 5804
-
Experimental combo targets Hard-to-Treat pancreatic cancer
Disease control OngoingThis study is being done to test the safety and effectiveness of combining ZN-c3 and Gemcitabine in participants with pancreatic cancer. The names of the study drugs involved in this study are: * ZN-c3 (a small molecule inhibitor of the WEE1 tyrosine kinase) * Gemcitabine (a nu…
Phase: PHASE2 • Sponsor: Brandon Huffman, MD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New asthma drug shows promise in early trial
Disease control CompletedThis is a Phase 2a, multicentre, randomised, placebo-controlled, double-blind, parallel-group study to evaluate the efficacy, safety and PK of AZD4604 administered BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontro…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo aims to wipe out rare bladder cancer before surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn about the efficacy and safety of neoadjuvant adebrelimab plus etoposide and cisplatin in patients with neuroendocrine bladder carcinoma. The main questions it aims to answer are: * The pathologic complete response rate at radical cyste…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New pill could offer relief for chronic hives sufferers
Disease control OngoingThe purpose of the core phase of the trial is to assess the efficacy, safety and tolerability of remibrutinib (LOU064) 25 milligrams (mg) twice a day (b.i.d.) over placebo for 24 weeks and in comparison to omalizumab 300 mg every 4 weeks (q4w) for 52 weeks in participants with ch…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Nasal spray could tame brain inflammation in progressive MS
Disease control OngoingForalumab is a human anti-CD3 monoclonal antibody being developed for the treatment of autoimmune and inflammatory diseases. The goal of this Phase 2a, randomized, double-blind placebo-controlled, multicenter dose-ranging study is to evaluate the use of nasal foralumab in patien…
Phase: PHASE2 • Sponsor: Tiziana Life Sciences LTD • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New stent aims to keep multiple heart arteries open
Disease control ENROLLING_BY_INVITATIONThe investigators intend to establish a multicenter prospective observational study by enrolling and tracking patients with multivessel coronary artery disease (MVCAD) using Genoss DES, a device manufactured with pure domestic technology. The study aims to evaluate the efficacy a…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a cancer drug ease long COVID? new trial tests LAU-7b
Symptom relief CompletedESSOR is a double-blind, placebo-controlled study of the orally-administered antiviral and inflammation-controlling LAU-7b for the treatment of adults with Long COVID and moderate to severe symptoms.
Phase: PHASE2, PHASE3 • Sponsor: Laurent Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New rehab program shows promise for long COVID sufferers
Symptom relief CompletedAbout 10-20% of persons who contract SARS CoV-2 will experience persistent post-acute sequelae of SARSCoV-2 infection (referred here as PASC). While treatments offered at emerging outpatient COVID recovery clinics are being informed by previous similar diseases, the need is great…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New ultrasound technique could end the need for surgery to diagnose endometriosis
Diagnosis ENROLLING_BY_INVITATIONEndometriosis is a benign gynecological disease characterized by uterine-like cells growing outside the uterus, leading to pain, infertility, and inflammation. Endometriosis most commonly occurs in the forms of Superficial Endometriosis (SE), Deep Endometriosis and Ovarian Endome…
Sponsor: McMaster University • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
AI and MRI join forces to spare cervical cancer patients from bladder and bowel harm
Symptom relief Recruiting nowConcurrent chemoradiotherapy (CCRT), consisting of external beam radiotherapy (EBRT) and chemotherapy, followed by brachytherapy (BT) is the standard of care for patients with locally advanced cervical carcinoma. In current clinical practice, conventionally, one radiotherapy plan…
Phase: NA • Sponsor: Juergen Debus • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Diabetes pills may fight fatty liver, study finds
Disease control CompletedStudy question 1:Could SGLT2-I improve hepatic fibrosis, steatosis, and inflammatory markers in type 2 diabetic patients with Metabolic associated steatotic liver disease Question 2:Which drug of SGLT2-I group is more effective in improving metabolic associated steatotic liver di…
Phase: PHASE3 • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Old gout drug may tame deadly heart inflammation
Disease control Recruiting nowTwo-parallel groups randomized, single-blinded, multi-center phase III controlled trial in patients with chronic inflammatory cardiomyopathy to assess the efficacy of colchicine and associated prospective registry to assess the prognostic value of positive genetic testing in this…
Phase: PHASE3 • Sponsor: Niguarda Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo therapy offers hope for kids with tough leukemia
Disease control Recruiting nowHEM-iSMART is a master protocol which investigates multiple investigational medicinal products in children, adolescents and young adults (AYA) with relapsed/refractory (R/R) ALL and LBL. Sub-protocol D is a phase I/II trial evaluating the safety and efficacy of trametinib in comb…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
New hope for myeloma patients as platform trial tests multiple treatments
Disease control Recruiting nowCO43923 is a platform study that will evaluate the safety, efficacy, and pharmacokinetics (PK) of multiple treatment combinations, as monotherapy or in combination, in participants with multiple myeloma (MM). The study is designed with the flexibility to open new treatment substu…
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New diabetes drug HTD1801 put to the test in 551-Person trial
Disease control CompletedThe goal of this clinical study is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with metformin.
Phase: PHASE3 • Sponsor: HighTide Biopharma Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Head elevation after stroke: simple move, big impact?
Disease control CompletedThe aim of this trial is to investigate whether head elevation position after endovascular treatment can improve the 90-day functional outcome of acute large vessel occlusion in the anterior circulation.
Phase: NA • Sponsor: Zhengzhou Yuan • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New heart-zapping technique tested to improve irregular heartbeat treatment
Disease control OngoingPulmonary vein isolation (PVI) is very effective for rhythm control in patients with paroxysmal atrial fibrillation (AF), but less successful in patients with persistent AF. Adding posterior wall ablation (PWA) to PVI is among the most promising ablation strategies to improve arr…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a different anesthetic lower the risk of Post-Surgery confusion?
Disease control CompletedThe investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anesthesia (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Radioactive cocktail targets Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this trial is to estimate the recommended dose (RD) of \[177Lu\]Lu-NeoB in combination with ribociclib and fulvestrant in participants with estrogen receptor (ER) positive (ER+), human epidermal growth factor receptor-2 (HER2) negative (HER2-) and gastrin releasing…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New study aims to boost cervical cancer care for women with HIV
Knowledge-focused Recruiting nowWhile there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to lev…
Phase: NA • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC